dirk haussecker, page-23

Yeah, truliapro! I second all the question marks in your post. Benitec is in a good place to move forward. Back in August last year we really needed more positive information. Most of the shareholder posts are much better this year. Today we have more confident shareholders in the US and Australia! Stock moves up regardless of news. That is because there is value in having the only ddrnai medication in the clinic with proof of transfection. I first imagined viral vectors back in 1993. It is awesome using the "needle" part of a virus to "inject" medicine into liver cells. . . and the cell continues to make copies of the medicine. . . This is known to work at many levels of testing . . . And now we have a clinical trial that is in patients.